Bosutinib-induced lung injury: a report of two cases and literature review

The prognosis of patients with chronic myeloid leukemia (CML) has improved dramatically since the development of tyrosine kinase inhibitors (TKIs). Three second-generation TKIs, including bosutinib, are currently approved for treatment of CML, and show a faster and deeper clinical response than imat...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Naoki, Takaku, Tomoiku, Tsukune, Yutaka, Yasuda, Hajime, Ochiai, Tomonori, Yamada, Kohei, Nakazawa, Hiroki, Hotta, Saori, Nishimaki, Takayasu, Takagi, Haruhi, Takahashi, Kazuhisa, Komatsu, Norio, Ando, Miki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884415/
https://www.ncbi.nlm.nih.gov/pubmed/35229254
http://dx.doi.org/10.1007/s12185-022-03304-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884415/
https://www.ncbi.nlm.nih.gov/pubmed/35229254
http://dx.doi.org/10.1007/s12185-022-03304-0

Ejemplares similares